scanX
Marksans Pharma

Marksans Pharma

184.29
-2.45
(-1.31%)
Market Cap
8,464.70 Cr
EPS
8.40
PE Ratio
24.17
Dividend Yield
0.43 %
Industry
Healthcare
52 Week High
358.70
52 Week Low
171.00
PB Ratio
3.43
Debt to Equity
0.12
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from2 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %

Company News

View All News
Caret
neutral
Marksans Pharma Reports Mixed Q1 Results with Revenue Growth but Profit Decline1 day ago
Marksans Pharma announced its Q1 financial results showing revenue growth to 6.2 billion rupees from 5.9 billion rupees year-over-year. However, the company's consolidated net profit declined to 583 million rupees compared to 888 million rupees in the same period last year. EBITDA decreased to 1 billion rupees from 1.3 billion rupees year-over-year, with EBITDA margin compressing to 16.15% from 21.72% in the previous year's corresponding quarter.

Peer Comparison Compare Peers on Screener

Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
Sun Pharmaceutical
1,639.80
#1 3,89,220.10
33.93
#1 54,729.00
9.71
#1 10,980
-19.84
46.24
Divis Laboratories
6,100.50
1,58,245.80
68.62
9,712.00
18.67
2,191
26.74
35.70
Cipla
1,561.00
1,22,900.80
22.78
28,409.50
7.12
5,291
9.88
62.21
Torrent Pharmaceuticals
3,617.80
1,22,723.70
60.80
11,539.40
6.99
1,911
19.91
57.51
Dr Reddys Laboratories
1,253.40
1,01,842.70
#1 17.93
33,741.20
16.73
5,725
1.26
51.29
Mankind Pharma
2,466.00
1,00,322.00
53.08
12,744.20
#1 20.90
2,007
-18.14
43.32
Zydus Life Science
988.60
96,160.80
20.70
23,511.00
18.55
4,615
2.60
57.92
Lupin
1,989.80
88,772.50
24.00
22,909.50
13.74
3,306
#1 51.64
58.30
Abbott
32,940.00
69,187.70
48.57
6,684.70
9.64
1,414
11.55
45.62
Alkem Laboratories
5,388.50
61,564.00
27.08
13,458.30
3.70
2,216
21.39
70.92

Automatic Screeners on ScanX

Community
7% near 52 Week Low
Forecast
Actual
Growth Rate
Revenue Growth
20.89 %
Net Income Growth
21.50 %
Cash Flow Change
-10.31 %
ROE
1.79 %
ROCE
-1.58 %
EBITDA Margin (Avg.)
-2.67 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
171
210
256
217
210
187
187
215
192
221
274
219
199
239
268
249
257
247
264
288
335
331
360
355
336
355
370
375
433
450
467
498
497
510
550
591
577
606
653
710
724
626
Expenses
132
160
204
187
206
173
180
188
177
192
249
190
195
200
232
212
232
213
223
240
266
261
273
267
235
272
301
305
354
361
372
403
376
398
417
453
450
462
506
543
582
520
EBITDA
39
50
51
31
4
14
7
27
15
29
25
29
4
39
36
36
25
35
41
47
69
70
87
88
101
83
69
70
79
89
94
94
121
112
133
138
126
143
147
167
142
106
Operating Profit %
23 %
24 %
20 %
14 %
2 %
7 %
0 %
12 %
4 %
13 %
9 %
13 %
2 %
15 %
14 %
15 %
6 %
13 %
13 %
16 %
21 %
21 %
23 %
25 %
29 %
22 %
17 %
16 %
15 %
17 %
18 %
16 %
23 %
20 %
21 %
23 %
20 %
22 %
21 %
20 %
18 %
16 %
Depreciation
4
5
6
10
8
5
6
12
8
7
7
6
6
6
6
5
6
5
5
7
10
7
19
9
1
8
7
9
21
11
14
13
14
14
18
22
21
20
20
21
23
23
Interest
1
3
3
2
2
1
1
2
2
2
3
2
4
2
3
2
2
2
3
2
2
2
2
2
3
1
2
1
5
2
3
2
2
2
2
3
5
3
3
3
3
6
Profit Before Tax
36
45
43
19
0
7
-0
13
-1
20
15
21
-6
30
28
30
17
28
34
38
58
61
66
78
97
75
60
60
53
76
78
79
104
97
114
113
100
120
125
143
116
77
Tax
10
13
7
-0
4
2
-1
2
2
5
4
4
1
6
7
4
7
5
8
9
15
12
15
19
18
12
14
12
23
16
18
17
22
26
30
30
23
31
27
38
25
18
Net Profit
26
32
36
19
-4
5
1
12
-3
14
10
18
-7
25
21
25
10
23
26
30
43
49
51
59
80
63
46
48
30
60
60
62
83
70
84
83
78
89
98
105
91
58
EPS in ₹
0.61
0.77
0.85
0.44
-0.14
0.11
0.02
0.24
0.00
0.33
0.23
0.41
-0.17
0.58
0.48
0.60
0.21
0.52
0.63
0.71
1.00
1.20
1.21
1.42
1.93
1.51
1.11
1.20
0.69
1.46
1.52
1.56
1.97
1.52
1.84
1.84
1.73
1.96
2.13
2.31
2.00
1.29
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
676
722
752
729
804
903
1,229
1,640
2,190
2,681
3,240
Fixed Assets
166
270
267
279
270
303
309
428
486
776
982
Current Assets
509
440
484
449
531
594
903
1,201
1,675
1,863
2,204
Capital Work in Progress
0
0
0
0
0
0
12
3
10
9
27
Investments
0
0
0
0
0
0
0
0
1
27
1
Other Assets
510
453
485
450
534
600
908
1,209
1,694
1,869
2,230
Total Liabilities
676
722
752
729
804
903
1,229
1,640
2,190
2,681
3,240
Current Liabilities
286
259
296
233
233
229
299
356
341
390
477
Non Current Liabilities
2
0
16
16
18
25
25
61
84
205
273
Total Equity
388
463
440
480
553
649
905
1,223
1,765
2,086
2,489
Reserve & Surplus
326
401
393
430
502
595
846
1,068
1,700
2,020
2,422
Share Capital
53
53
41
41
41
41
41
41
45
45
45
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
138
-150
-10
15
-7
60
119
94
176
21
93
Investing Activities
-33
-123
-21
-39
-14
-60
-45
-84
-259
-141
-49
Operating Activities
155
31
14
50
27
233
179
99
237
230
207
Financing Activities
17
-58
-4
3
-21
-114
-15
80
198
-69
-65
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Jan 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
48.25 %
48.25 %
48.25 %
48.25 %
48.25 %
48.25 %
48.60 %
49.00 %
43.80 %
43.85 %
43.85 %
43.85 %
43.85 %
43.85 %
43.87 %
43.87 %
43.87 %
43.87 %
43.87 %
FIIs
1.00 %
0.59 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
10.88 %
10.88 %
10.88 %
10.88 %
10.88 %
15.57 %
18.60 %
21.31 %
21.96 %
22.20 %
19.88 %
DIIs
0.09 %
0.34 %
0.34 %
0.34 %
0.46 %
0.95 %
0.95 %
0.96 %
0.87 %
1.46 %
3.65 %
3.15 %
3.82 %
5.17 %
3.75 %
4.10 %
4.30 %
4.56 %
5.50 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.15 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
41.50 %
41.71 %
42.41 %
42.47 %
41.36 %
40.77 %
39.76 %
39.69 %
35.19 %
34.42 %
32.36 %
32.12 %
30.80 %
30.91 %
29.47 %
26.77 %
26.24 %
25.77 %
26.75 %
Others
9.15 %
9.11 %
9.00 %
8.94 %
9.78 %
10.04 %
10.69 %
10.34 %
9.25 %
9.39 %
9.25 %
10.00 %
10.64 %
4.49 %
4.31 %
3.95 %
3.63 %
3.59 %
4.00 %
No of Share Holders
0
1,35,271
1,88,888
2,01,451
2,14,998
2,20,090
2,21,359
2,17,743
2,13,123
1,98,382
1,88,447
2,07,937
2,37,377
2,54,699
2,35,500
2,48,845
2,59,813
2,57,273
2,56,221

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.05 0.05 0.05 0.1 0.25 0.25 0.5 0.6 0.8
Dividend Yield (%) 0.00 0.16 0.2 0.36 0.2 0.55 0.34 0.33 0.27 0.43

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
12 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 12 Aug 2025 237.25 210.08
08 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
 08 Aug 2025 256.75 214.35
01 Aug 2025 DIVIDEND Dividend
₹ 0.80 /share
 01 Aug 2025 241.40 227.80
19 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 19 May 2025 225.54 241.40
11 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 11 Feb 2025 259.15 267.40
12 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 12 Nov 2024 266.10 288.60
24 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
 24 Sept 2024 209.01 314.54
17 Sept 2024 DIVIDEND Dividend
₹ 0.60 /share
 17 Sept 2024 169.55 293.85
07 Jun 2023 DIVIDEND Dividend
₹ 0.50 /share
 07 Jun 2023 75.73 89.51
23 Aug 2022 DIVIDEND Dividend
₹ 0.25 /share
 19 Aug 2022 46.70 50.80
17 Sept 2021 DIVIDEND Dividend
₹ 0.25 /share
 15 Sept 2021 73.95 71.05

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication6 hours ago
Results For The Quarter Ended June 30 20251 day ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release1 day ago
Announcement under Regulation 30 (LODR)-Investor Presentation1 day ago
Board Meeting Outcome for Outcome Of Board Meeting Held Today For Publication Of Financial Results1 day ago
Voting Results For The 33Rd Annual General Meeting Of The Company.4 days ago
Shareholder Meeting / Postal Ballot-Scrutinizers Report4 days ago
Shareholder Meeting / Postal Ballot-Outcome of AGM4 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release5 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation8 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 28, 2025
Re-Appointment Of Mr. Mark Saldanha For A Period Of 5 Years With Effect From 06-10-2025Jul 25, 2025
Addendum To The Notice Of 33Rd Annual General MeetingJul 25, 2025
Board Meeting Outcome for Outcome For Consideration And Re-Appointment Of Mr. Mark Saldanha Subject To The Approval Of The Shareholders At The Ensuing Annual General MeetingJul 25, 2025
Board Meeting Intimation for Consideration And Approval Of Financial Results For The Quarter Ended June 30 2025Jul 24, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 17, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 17, 2025
Business Responsibility and Sustainability Reporting (BRSR)Jul 16, 2025
Reg. 34 (1) Annual Report.Jul 16, 2025
Shareholders Annual General Meeting To Be Held On August 8 2025Jul 16, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 14, 2025
Announcement under Regulation 30 (LODR)-Date of payment of DividendJul 11, 2025
Announcement under Regulation 30 (LODR)-Dividend UpdatesJul 11, 2025
The Annual General Meeting Is Proposed To Be Held On August 8 2025.Jul 11, 2025
Appointment Of Secretarial Auditor For A Term Of 5 Years.Jul 11, 2025
The Board Fixes August 1 2025 As The Record Date For The Purpose Of Dividend.Jul 11, 2025
Board Meeting Outcome for Board Meeting Outcome For Consideration And Approval Of Annual General Meeting Related Matters.Jul 11, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 09, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 30, 2025
Closure of Trading WindowJun 25, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 19, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 16, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 30, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 26, 2025
Newspaper Advertisement Of Financial Results For The Quarter And Year Ended March 31 2025May 22, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 20, 2025
Audited Results For The Year Ended March 31 2025May 19, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateMay 19, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 19, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 19, 2025
Board Meeting Outcome for Board Meeting Outcome For Consideration And Approval Of Audited Results For The Year Ended March 31 2025May 19, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 19, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 15, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 09, 2025
Board Meeting Intimation for To Consider And Approve Audited Financial Results (Both Standalone And Consolidated) For The Quarter And Year Ended March 31 2025 And To Consider Recommendation Of Dividend On Equity Shares For The Financial Year 2024-25 If AnMay 08, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 28, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 10, 2025
Announcement under Regulation 30 (LODR)-CessationMar 31, 2025
Closure of Trading WindowMar 26, 2025

Technical Indicators

RSI(14)
Oversold
18.46
ATR(14)
Less Volatile
10.14
STOCH(9,6)
Oversold
11.19
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
-4.09
ADX(14)
Strong Trend
33.74
UO(9)
Bearish
31.70
ROC(12)
Downtrend But Slowing Down
-17.44
WillR(14)
Oversold
-89.10
Bearish
4
Neutral
2
Bullish
3

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Old Bridge Focused Fund Direct - Growth
0.00%
-2160000
-2.96%
-3.15%
Bandhan Small Cap Fund Direct-Growth
0.40%
441820
0.00%
0.09%
UTI Multi Cap Fund Direct-Growth
1.31%
225000
0.11%
1.31%
Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth
0.61%
32120
-0.08%
-0.10%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.35%
-114
-0.05%
-0.07%
Groww Nifty Total Market Index Fund Direct - Growth
0.02%
79
0.00%
0.00%
Angel One Nifty Total Market Index Fund Direct - Growth
0.02%
30
0.00%
0.00%
Mirae Asset Nifty Total Market Index Fund Direct-Growth
0.02%
13
0.00%
0.00%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.02%
-1
-0.01%
-0.01%
Motilal Oswal Quant Fund Direct-Growth
0.88%
0
-0.11%
0.88%
UTI Aggressive Hybrid Fund Direct Fund-Growth
0.53%
0
-0.08%
-0.10%
Kotak MNC Fund Direct-Growth
2.03%
0
-0.27%
-0.30%
Samco Active Momentum Fund Direct - Growth
0.00%
0
0.00%
0.00%
Samco Multi Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
TRUSTMF Flexi Cap Fund Direct - Growth
0.00%
0
0.00%
0.00%
TRUSTMF Small Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Kotak Special Opportunities Fund Direct-Growth
2.91%
0
-0.21%
-0.25%
UTI Healthcare Fund Direct-Growth
1.50%
0
-0.30%
-0.14%
UTI Large & Mid Cap Fund Direct-Growth
0.50%
0
-0.07%
-0.12%
Kotak Healthcare Fund Direct - Growth
2.06%
0
-0.48%
-0.59%
UTI Retirement Fund Direct
0.26%
0
-0.04%
-0.04%
UTI Small Cap Fund Direct - Growth
0.83%
0
-0.11%
-0.18%
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth
0.00%
0
0.00%
0.00%
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Fundamental Screeners
Technical Screeners
Candlestick Screeners
Price & Volume Screeners
Intraday Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
Sensex Companies
Nifty 50 Companies
Nifty Next 50 Companies
Nifty Bank Companies
Finnifty Companies
Defence Stocks
Semi Conductor Stocks
Renewable Energy Stocks
AI Stocks
Cement Stocks
Penny Stocks
Multibagger Stocks
Breakout Stocks
Dividend Stocks
Large Cap Stocks
Mid Cap Stocks
Small Cap Stocks
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2025 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104